Edwards Lifesciences Corporation Common Stock vs Range Nuclear Renaissance ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Range Nuclear Renaissance ETF trades at $60.88 (market cap $713.14M). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 69.3× Range Nuclear Renaissance ETF's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Range Nuclear Renaissance ETF nearer its low. Which is the better fit depends on your goals.
| EW | NUKZ | |
|---|---|---|
Market Cap | $49.44B | $713.14M |
Volume | 3,508,027 | 118,259 |
Sector | Health | Sector/Thematic |
52-Week High | $95.18 | $76.23 |
52-Week Low | $72.65 | $60.23 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 17 Days |
Trailing returns across standard periods
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.
Read more on NUKZ →